European Union
In force Implementing regulation 19 units
Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017 confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution (Text with EEA relevance. )
Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017 confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution (Text with EEA relevance. )eu-implementing-regulation-2017-11-13-2065Nov 13, 2017
- Preamble 1
- recital 1 recital 1
- recital 2 recital 2
- recital 3 recital 3
- recital 4 recital 4
- recital 5 recital 5
- recital 6 recital 6
- recital 7 recital 7
- recital 8 recital 8
- recital 9 recital 9
- recital 10 recital 10
- recital 11 recital 11
- recital 12 recital 12
- recital 13 recital 13
- recital 14 recital 14
- Article 1 Confirmation of the conditions of approval
- Article 2 Amendment to the Annex to Implementing Regulation (EU) 2015/408
- Article 3 Deferred application of Article 2
- Article 4 Entry into force